THE IMPACT OF I-123 METAIODOBENZYLGUANIDINE SCINTIGRAPHY ON DIAGNOSTICS AND FOLLOW-UP OF NEUROBLASTOMA

被引：13

作者：

ABRAHAMSEN, J ^{[1
]}

LYCK, B ^{[1
]}

HELGESTAD, J ^{[1
]}

FREDERIKSEN, PB ^{[1
]}

机构：

[1] ODENSE UNIV HOSP,DEPT PEDIAT,DK-5000 ODENSE C,DENMARK

来源：

ACTA ONCOLOGICA | 1995年 / 34卷 / 04期

关键词：

D O I：

10.3109/02841869509094015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The present retrospective study includes all children suspected for having neuroblastoma, admitted to Odense University Hospital in September 1984 through December 1993. Thirty-six children at the age range of 1 month to 14 years and 10 month were investigated with I-123-metaiodobenzylguanidine (MIBG). Nineteen children had histologically verified neuroblastoma. Several MIBG scintigraphic examinations were made in all but one of these 19 children. Positive MIBG scintigraphy strengthened the diagnosis and indicated the volume and location of the tumour at diagnosis and during the treatment period. In a few patients only there was some disagreement between results obtained with MIBG scintigraphy and standard investigations as CT-scanning or ultrasonography. MIBG scintigraphy in all cases turned out to be the most sensitive modality.

引用

页码：505 / 510

页数：6

共 36 条

[1]

BOMANJI J, 1987, J NUCL MED, V28, P973

[2]

Bouvier J F, 1988, Prog Clin Biol Res, V271, P707

[3]

CARLSEN NLT, 1992, AM J PEDIAT HEMATOL, V14, P103

[4]

CORBETT R, 1991, PROG CLIN BIOL RES, V366, P479

[5]

DAUBENTON JD, 1987, CANCER, V59, P1586, DOI 10.1002/1097-0142(19870501)59:9<1586::AID-CNCR2820590910>3.0.CO

[6]

2-D

[7] STAGING AND TREATMENT OF NEURO-BLASTOMA [J].

EVANS, AE .

CANCER, 1980, 45 (07) :1799-1802

[8]

GEATTI O, 1985, J NUCL MED, V26, P736

[9]

GELFAND MJ, 1993, SEMIN NUCL MED, V23, P231, DOI 10.1016/S0001-2998(05)80104-7

[10]

GORDON I, 1990, J NUCL MED, V31, P129

← 1 2 3 4 →